Showing results (521-530 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|September 9, 2017
AN-7, a butyric acid prodrug, sensitizes cutaneous T-cell lymphoma cell lines to doxorubicin via inhibition of DNA double strand breaks repairLilach Moyal, Neta Goldfeiz, Batia Gorovitz, et al.Investigational New Drugs|February 15, 2018
Proteasome inhibition and mechanism of resistance to a synthetic, library-based hexapeptideRuud Oerlemans, Celia R Berkers, Yehuda G Assaraf, et al.Investigational New Drugs|February 18, 2018
Drug approval based on randomized phase 3 trials for relapsed malignancy: analysis of oncologic drugs granted accelerated approval, publications and clinical trial databasesSumimasa Nagai, Keiya OzawaInvestigational New Drugs|February 18, 2018
Safety, tolerability, and preliminary activity of IMGN529, a CD37-targeted antibody-drug conjugate, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: a dose-escalation, phase I studyAnastasios Stathis, Ian W Flinn, Sumit Madan, et al.Investigational New Drugs|March 10, 2018
Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapyHyungwoo Cho, Dok Hyun Yoon, Kyu-Pyo Kim, et al.Investigational New Drugs|March 3, 2018
Preclinical investigation of a potent geranylgeranyl diphosphate synthase inhibitorStaci L Haney, Yashpal S Chhonker, Michelle L Varney, et al.Investigational New Drugs|March 6, 2018
Histone deacetylase inhibitor chidamide induces growth inhibition and apoptosis in NK/T lymphoma cells through ATM-Chk2-p53-p21 signalling pathwayJianan Zhou, Canjing Zhang, Xianxian Sui, et al.Investigational New Drugs|March 6, 2018
PIK3CA mutation sensitizes breast cancer cells to synergistic therapy of PI3K inhibition and AMPK activationSonglin Liu, Yunhong Tang, Maomao Yan, et al.Investigational New Drugs|January 10, 2018
The in vitro assessment of dipyridophenazine complexes in H-ras oncogene transformed rat embryo fibroblast 5RP7 cell lineAyse Kaplan, Kadriye Benkli, Ayse Tansu KoparalInvestigational New Drugs|February 3, 2018
Pre-clinical effects of metformin and aspirin on the cell lines of different breast cancer subtypesMaria Eduarda Azambuja Amaral, Laura Roesler Nery, Carlos Eduardo Leite, et al.Pageof 372